Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
01/2014
01/23/2014WO2013082345A8 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
01/23/2014US20140024815 Dendrimers with interior and exterior functionalities comprising of azide or alkyne groups for post-functionalization by huisgen click cycloaddition
01/22/2014EP2687516A1 Inhibitors of C-FMS Kinase
01/22/2014CN103524468A Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
01/21/2014US8633326 Method for preparing taxane derivatives
01/21/2014US8633236 Compounds, compositions and methods
01/21/2014US8633210 Triazole compounds useful as protein kinase inhibitors
01/16/2014WO2014010824A1 Heterocyclic compound and organic electronic element containing same
01/16/2014WO2014010823A1 Heterocyclic compound and organic electronic element containing same
01/16/2014WO2014010737A1 Oxime-substituted amide compound and pest control agent
01/16/2014WO2014008992A1 Pyrimidine pyrazolyl derivatives
01/16/2014US20140016179 Pigment-based inks
01/15/2014CN103517899A Chromene compound
01/15/2014CN103509647A Method for preparing silybum marianum oil rich in silymarin
01/15/2014CN103509044A Beraprost sodium intermediates and preparation method thereof
01/15/2014CN103508981A New piperazine derivative and medical applications
01/14/2014US8629197 Chemically patterned hydrogels, manufacture and use thereof
01/09/2014WO2014008197A1 Heterocyclic modulators of lipid synthesis
01/09/2014US20140011845 Chemical compounds
01/09/2014US20140007497 Biorefining compounds and organocatalytic upgrading methods
01/09/2014CA2877999A1 Heterocyclic modulators of lipid synthesis
01/08/2014EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core.
01/08/2014CN102239157B Diolefin compound, epoxy resin, curable resin composition and cured product
01/03/2014WO2014004064A1 Fungicidal heterocyclic carboxamides
01/03/2014WO2014002105A1 Compounds for the treatment of dyslipidemia and other diseases
01/03/2014CA2877862A1 Fungicidal heterocyclic carboxamides
01/01/2014CN103483291A 4,5-diaryl-1,3-selenazole compound, preparation method and use thereof
12/2013
12/31/2013CA2544678C Modulators of cellular adhesion
12/27/2013WO2013192352A1 Antibacterial agents: aryl myxopyronin derivatives
12/27/2013WO2013189237A1 Andrographolide analogue and application of andrographolide analogue to treatment
12/25/2013EP2676965A1 Aryl glycoside compound, preparation method and use thereof
12/25/2013EP2675798A1 Novel benzodioxole piperazine compounds
12/25/2013CN103467463A Lignin derivatives as well as preparation method and use thereof
12/25/2013CN103467423A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
12/25/2013CN103467282A Synthesis method of polysubstitution naphthol and derivative of polysubstitution naphthol
12/25/2013CN102311418B Preparation method for benzodihydropyran compound
12/24/2013US8613909 Cinnamic acid-based oligomers and uses thereof
12/19/2013WO2013188381A1 Pyridinone and pyridazinone derivatives
12/19/2013WO2013188253A1 Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides
12/19/2013CA2875016A1 Pyridinone and pyridazinone derivatives
12/18/2013EP2493885B1 Polyketide molecules as anticancer agents
12/18/2013EP2440204B1 Nicotinamide compounds useful as kinase modulators
12/18/2013CN103450165A 2,3-dehydrosilybin derivative, and preparation method and use thereof
12/18/2013CN103450129A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
12/17/2013US8609708 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
12/12/2013WO2013182263A1 Phenanthrene compounds for organic electronic devices
12/11/2013EP2671876A2 Pyrazine derivatives and their use as protein kinase inhbitors
12/11/2013CN103443097A Fused dihydrofurans as GPR119 modulators for the treatment of diabetes, obesity and related disorders
12/11/2013CN103435581A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
12/11/2013CN102161657B Mangiferin crystal I and preparation method thereof
12/10/2013US8604077 Ketal compounds from polyols and oxocarboxylates
12/05/2013WO2013180375A1 Composition and cured article comprising inorganic particles and epoxy compound having alkoxysilyl group, use for same, and production method for epoxy compound having alkoxysilyl group
12/05/2013US20130324577 Bicyclic compound and use thereof for medical purposes
12/05/2013US20130324525 Substituted heterocyclic compounds
12/04/2013EP2669279A1 Bicyclic compound and use thereof for medical purposes
12/04/2013EP2668181A1 Pyrazole compounds as crth2 antagonists
12/04/2013CN103420992A Method for preparing ketoside from gardenia
12/04/2013CN102219782B Method for extracting and separating viterxin and isovitexin from natural product
12/04/2013CN101646664B Furanone compounds
12/03/2013US8597706 Method for synthesizing 2-acetyl-1-pyrroline, stable ketal precursors thereof, and isotopically marked analogs
11/2013
11/28/2013WO2013177243A1 Sulfilimine and sulphoxide methods for producing festinavir
11/28/2013WO2013175388A1 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
11/28/2013WO2013174485A1 SUBSTITUTED ß-AMINO ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS
11/27/2013EP2666769A1 Substituted B-amino acid derivatives as CXCR3 receptor antagonist
11/27/2013EP2665719A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
11/27/2013CN103408602A Separation and preparation method for four glycoside chemical reference substances in Tibetan capillary artemisia
11/27/2013CN103408539A Production method of high-purity silibinin
11/27/2013CN103408538A Method for extracting silymarin
11/26/2013US8592057 Organic electroluminescence element, new compound for the same, display device and lighting device using the same
11/26/2013CA2759399C Inhibitors of the renal outer medullary potassium channel
11/21/2013WO2013171641A1 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171092A1 Plant growth regulating compounds
11/21/2013US20130310288 Ketal compounds and uses thereof
11/20/2013EP2663558A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
11/20/2013EP2346834B1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
11/20/2013CN103402960A Process for the preparation of alditol acetals
11/20/2013CN103402959A Method of making diacetal compound in aqueous medium
11/20/2013CN103402515A Sgc stimulators
11/20/2013CN103396383A Preparation method of chiral epoxy compound
11/19/2013CA2746307C Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
11/14/2013WO2013170155A2 Methods of purifying and identifying the presence of and levels of procyanidin oligomeric compounds
11/14/2013US20130303601 Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
11/14/2013US20130303544 Benzopyrone estrogen receptor regulator
11/13/2013EP2661432A1 Pyrrolidine derivatives as nk3 antagonists
11/13/2013CN103387587A Preparation method for entecavir intermediate
11/13/2013CN101974026B Allyl acyl silicon compound with two chiral centers in positions alpha and beta, preparation method and application
11/13/2013CN101883764B Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
11/13/2013CN101679279B Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
11/07/2013WO2013164321A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
11/07/2013US20130296583 Nebivolol and its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol
11/07/2013US20130296379 Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)Cyclopropanecarboxamido)-3-Methylpyridin-2-yl)Benzoic Acid
11/06/2013EP2660240A1 Benzopyrone estrogen receptor regulator
11/06/2013EP2658855A2 Novel polyketide compounds and methods of making same
11/06/2013EP2658851A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
11/06/2013CN103384712A Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/06/2013CN103384666A Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
11/06/2013CN103384662A Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
11/06/2013CN103382203A Puerarin derivative and synthetic method and application thereof
11/06/2013CN103382196A (E)-1-(8-benzopyranyl)-2-allyl-1-one and its analogues, and use thereof
11/06/2013CN102229578B Preparation method of 2-arylamino-1,3,4-oxadiazole compound
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 120